FolioLab
FolioLab vs Danelfin: same 1 to 10 scale, different questions
FolioLab and Danelfin both put a number from 1 to 10 on a stock, and both use AI to get there. That is where most of the similarity ends. The two scores answer different questions, are built in very different ways, and suit different jobs.
The short version
| FolioLab | Danelfin | |
|---|---|---|
| What the score means | Where a written analysis of one stock landed, from Bearish (1 to 2) to Bullish (9 to 10) | An estimate of the probability that a stock beats the market over the next three months, shown with a rating such as Buy |
| How it is made | A desk of AI roles built on large language models: three analysts, a bull and bear debate, a risk review and a final call | AI models that weigh thousands of technical, fundamental and sentiment indicators for each stock |
| What you read | A plain-English report: summary, the three analysts' signals, the bull and bear case, the thesis and the outlook | A stock page with the score, four sub-scores (fundamental, technical, sentiment, low risk) and the Alpha Signals behind them; AI price forecasts and buy, hold and sell trading parameters on paid plans |
| Coverage | U.S. stocks, one at a time, when you ask | U.S. and European stocks and ETFs, scored every day |
| Where | iPhone app | Website |
| Price | 2 free scans, then $9.99 for 5 scans or $14.99 a month for 10 | A limited free plan; paid plans from $29 a month ($22 a month billed yearly), each with a 14-day free trial |
| Best for | Understanding one company's case before you decide | Screening and ranking many stocks quickly |
Danelfin: a daily forecast across thousands of stocks
Danelfin is an AI stock analytics website. Its headline number, the AI Score, rates a stock from 1 to 10 by, in Danelfin's words, "the probability of beating the market in the next 3 months". Danelfin says its models weigh thousands of technical, fundamental and sentiment indicators for each stock, every day, across U.S. and European stocks and ETFs. Next to the AI Score sit four sub-scores, for fundamentals, technicals, sentiment and low risk, and the score comes with a rating: on the day we looked, Apple showed an AI Score of 8, rated Buy.
Danelfin is open about what the score is: its AI "calculates probabilities, not certainties". To show what drives a score, it lists Alpha Signals, the individual indicators that pushed a stock's probability up or down. Around the score sit tools built for breadth and for trading: rankings by sector, trade ideas, AI price forecasts, buy, hold and sell trading parameters, portfolio tracking, and a track record for its scores. The free plan shows a slice of this (the top-ranked stocks and ten stock reports a month), and the paid plans open up the rest.
The strength of that approach is scale. If you want to sort a large universe of stocks by one consistent, quantitative measure every morning, that is exactly what it is built to do.
FolioLab: a written case for one stock
FolioLab works the other way around. You pick one U.S. stock and tap Scan, and a research desk run entirely by AI goes to work on it: three analysts read the technicals, the fundamentals and the sentiment; a bull and a bear researcher argue the case over several rounds; three risk views stress-test the conclusion; and a head of research makes the final call. A few minutes later you get a report that explains its reasoning in plain English. How a FolioLab scan works walks through every step.
The research score at the top is the conclusion of that analysis, not a prediction. The head of research's read sets the band, from Bearish to Bullish, and the analysts' lean picks the number within it. Below the score you can read both sides of the argument and decide how much weight to give each.
The strength of that approach is depth. If you already have a company in mind and want to understand the case for and against it, the report gives you the reasoning, not just a rating.
Two 9s that mean different things
Because both scales run from 1 to 10, it is tempting to read the numbers the same way. They are not the same measurement.
- A Danelfin 9 says its models see a high probability that the stock beats the market over the next three months.
- A FolioLab 9 says the research desk's analysis came out bullish, with broad agreement among the analysts underneath that call. It is a summary of an argument you can read, with an outlook for the next 1 to 6 months and for 1 to 2 years and beyond.
There is a difference in posture too. Danelfin pairs its scores with ratings like Buy and, on its paid plans, with trade ideas, price forecasts and buy, hold and sell levels. FolioLab stays on the research side on purpose: its reports make no buy or sell calls and set no price targets, and its outlook is a direction, not a price.
Neither number is a guarantee, and neither one knows your goals or your portfolio.
Where each one is stronger
Danelfin is stronger when you want
- to scan and rank hundreds or thousands of stocks at once, updated every day;
- a consistent quantitative signal with a published track record;
- trade ideas and price forecasts alongside the score;
- European stocks or ETFs.
FolioLab is stronger when you want
- to make your own informed decision, not follow someone else's rating;
- to understand the reasoning behind the score, in plain English, for one company in depth;
- to weigh the bull case and the bear case side by side, and judge for yourself which one holds up;
- research that informs your decision instead of making it for you, with no buy or sell calls to follow;
- to start without an account or a subscription, and pay per scan if you only research now and then.
Which should you use?
It depends on the job. If you are looking for ideas across the whole market, a screening tool like Danelfin fits. If you already have a stock in mind and want to know whether the story holds up, FolioLab fits. Plenty of investors will find a use for both: one to narrow the field, the other to read the case for the names that make the cut.
A few things to keep in mind
- AI can be wrong. Every FolioLab report is researched and written entirely by AI (large language models), and two scans of the same stock can come out differently. Danelfin's scores are probabilities, as it says itself.
- Do your own research. This post, like every FolioLab report, is research and education, not investment advice.
- Names. Danelfin is a trademark of its owner. FolioLab is not affiliated with Danelfin.
Want to read the case for a stock you follow? Get FolioLab on the App Store. Your first two scans are free.